Consistent with these findings, Sanger sequencing of PCR products amplified with high-fidelity DNA polymerase confirmed increased APOBEC3D and AZIN1 RNA editing in BC versus CP CML progenitors (Additional file 3: Figure S1A-D). The gene discussed is APOBEC3D; the disease is breast cancer.